Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/19/1995 | EP0662833A1 Aqueous composition |
07/19/1995 | EP0662831A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
07/19/1995 | EP0662826A1 Pharmaceutical compositions containing nonionic surfactants |
07/19/1995 | EP0662823A1 Process for the preparation of drug pellets |
07/19/1995 | EP0662819A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9- (2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof. |
07/19/1995 | EP0662782A1 Pp14-based therapy |
07/19/1995 | CN1105240A Pharmaceutical composition |
07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
07/18/1995 | US5434242 Catalyst-free resorbable homopolymers and copolymers |
07/18/1995 | US5434241 Biodegradable poly(lactic acid)s having improved physical properties and process for their preparation |
07/18/1995 | US5434187 Adding an aliphatic dicarboxylic acid and a salt thereof to eye drops to extend dwell time of drops |
07/18/1995 | US5434124 Herbicides |
07/18/1995 | US5434076 Tumor-specific, cell surface-binding monoclonal antibodies |
07/18/1995 | US5433959 Antisecretory agent such as lansoprazole stabilized by basic inorganic salts |
07/18/1995 | US5433955 Site specific in vivo activation of therapeutic drugs |
07/18/1995 | US5433950 Flexible collodion compositions |
07/18/1995 | US5433946 Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases |
07/18/1995 | CA2017801C Functionalized silicone oil aqueous dispersions curable into an elastomer by loss of water |
07/18/1995 | CA1336323C Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base, with elimination, in solution, of the bitter taste, burning of the throat and intestinal toxicity |
07/18/1995 | CA1336322C Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
07/13/1995 | WO1995018636A2 Hepatocyte-targeted drug conjugates |
07/13/1995 | WO1995018635A1 Low molecular weight hyaluronic acid with peptide or protein |
07/13/1995 | WO1995018627A1 Method of making polymers having specific properties |
07/13/1995 | WO1995018623A1 Oligomeric compounds having nitrogen-containing linkages |
07/13/1995 | WO1995018603A1 Transdermal device containing polyvinylpyrrolidone as solubility enhancer |
07/13/1995 | WO1995018598A1 Pharmaceutical ointment base |
07/13/1995 | WO1995013095A3 Therapy |
07/13/1995 | DE4400640A1 Diagnosis and treatment of malignant tumours |
07/13/1995 | CA2181082A1 Oligomeric compounds having nitrogen-containing linkages |
07/13/1995 | CA2180755A1 Pharmaceutical ointment base |
07/13/1995 | CA2180348A1 Hepatocyte-targeted drug conjugates |
07/12/1995 | EP0662513A1 Methods for preventing degradation of protein C |
07/12/1995 | EP0662479A2 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
07/12/1995 | EP0662322A2 Pharmaceutical composition for controlled release |
07/12/1995 | EP0662321A1 Method for producing osmosis-controlled tablets avoiding the use of chlorinated hydrocarbons |
07/12/1995 | EP0662320A1 Dry gel composition |
07/12/1995 | EP0662319A1 Cosmetic and/or dermatologic composition for the treatment of aging containing ceramides, and its use |
07/12/1995 | EP0662318A1 Cosmetic and/or dermatological composition containing salicylic acid derivatives and the solubilisation process of these derivatives |
07/12/1995 | EP0662125A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
07/12/1995 | EP0662002A1 Alginate-bioactive agent conjugates |
07/12/1995 | EP0662000A1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
07/12/1995 | EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
07/12/1995 | EP0661966A1 Ulcer prevention and treatment composition and method |
07/12/1995 | EP0661924A1 Surface treatment composition. |
07/12/1995 | EP0481042B1 Amphoteric hydrogel for medical devices |
07/12/1995 | EP0215942B1 Polynucleotide assay reagent and method |
07/12/1995 | CN1104896A Multifunction medicine for curing trauma |
07/11/1995 | US5432196 Anipamil |
07/11/1995 | US5432170 Fatty ester, nonionic surfactant |
07/11/1995 | US5431916 Polyvinylpyrrolidone, triester |
07/11/1995 | US5431914 Topical administration |
07/11/1995 | US5431909 Stabilization of human interferon |
07/11/1995 | US5431902 New medicament aerosol formulation based on fusafungine |
07/11/1995 | CA2139018A1 Cosmetic and/or dermatologic composition for the treatment of aging comprising ceramids, and its use |
07/11/1995 | CA2005143C Stabilized hydrophobic protein formulations of g-csf |
07/11/1995 | CA1336308C Polysaccharide-protein conjugates |
07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
07/06/1995 | WO1995018155A1 Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it |
07/06/1995 | WO1995018136A1 Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
07/06/1995 | WO1995017953A1 High internal phase water/oil emulsions and water/oil/water emulsions |
07/06/1995 | WO1995017909A1 Powdery pharmaceutical preparation and method of manufacturing same |
07/06/1995 | WO1995017908A1 Method for selective methionine starvation of malignant cells in mammals |
07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
07/06/1995 | WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
07/06/1995 | WO1995017885A1 Inhibitors of urokinase plasminogen activator |
07/06/1995 | WO1995017883A1 Water-in-oil lotion containing a corticosteroid |
07/06/1995 | WO1995017882A1 Corticosteroid-containing w/o emulsion lotion |
07/06/1995 | WO1995017831A1 Coprocessed galactomannan - glucomannan |
07/06/1995 | CA2180335A1 High internal phase water/oil emulsions and water/oil/water emulsions |
07/06/1995 | CA2180262A1 Method for selective methionine starvation of malignant cells in mammals |
07/06/1995 | CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
07/05/1995 | EP0661267A1 Chelating agent for attaching metal ions to proteins |
07/05/1995 | EP0661061A2 Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment |
07/05/1995 | EP0661060A2 Highly concentrated immunoglobulin composition and method to prepare it |
07/05/1995 | EP0661052A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
07/05/1995 | EP0661047A1 Pharmaceutical formulation containing diphenhydramine, talc, calamine and oat extract in an emulsified base and uses thereof |
07/05/1995 | EP0661045A1 Sustained-release hydrogel preparation |
07/05/1995 | EP0661037A1 Composition against skinaging acting simultaneously on the superficial and deep skinlayers |
07/05/1995 | EP0660723A1 Vp6 encapsulated drug delivery. |
07/05/1995 | EP0660721A1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells |
07/05/1995 | EP0660717A1 Aminosteroids for ophthalmic use |
07/05/1995 | EP0660714A1 Novel liposomal drug delivery systems |
07/05/1995 | EP0660704A1 A process for producing suppositories by compression and suppositories obtained by the process. |
07/05/1995 | EP0660702A1 Water-in-oil emulsions containing water-soluble alkyl glycosides |
07/05/1995 | EP0660687A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
07/05/1995 | EP0660676A1 Novel compositions. |
07/05/1995 | EP0660668A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
07/05/1995 | EP0493529B1 Yttrium and rare earth compounds catalyzed lactone polymerization |
07/05/1995 | CN1104492A Anti-inflammatory analgesic plaster |
07/05/1995 | CN1104488A Sustained releasable parenteral pharmaceutical preparations and method of producing the same |
07/05/1995 | CN1104487A Pharmaceutical granulate |
07/05/1995 | CA2112754A1 Returning malignant cells back to health |
07/04/1995 | US5430116 Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
07/04/1995 | US5430110 Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary |
07/04/1995 | US5430057 Parenteral busulfan for treatment of malignant disease |
07/04/1995 | US5430021 Hydrophobic drug delivery systems |
07/04/1995 | US5430017 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
07/04/1995 | US5429836 Maltodextrin and emulsifier feed and matrix for foods |
07/04/1995 | US5429824 Compound for diagnostic imaging a 4-(1,1,3,3-tetramethylbutyl) phenol polymer of ethylene oxide and formaldehyde |